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ABSTRACT
Position-specific incorporation of non-natural amino
acids into proteins is a useful technique in protein
engineering. In this study, we established a novel
selection system to obtain tRNAs that show high
decoding activity, from a tRNA library in a cell-free
translationsystemtoimprovetheefficiencyofincorp-
oration of non-natural amino acids into proteins. In
this system, a puromycin–tRNA conjugate, in which
the30-terminalAunitwasreplacedbypuromycin,was
used. The puromycin–tRNA conjugate was fused
to a C-terminus of streptavidin through the puro-
mycin moiety in the ribosome. The streptavidin–
puromycin–tRNA fusion molecule was collected
and brought to the next round after amplification of
the tRNA sequence. We applied this system to select
efficient frameshift suppressor tRNAs from a tRNA
library with a randomly mutated anticodon loop
derived from yeast tRNA
Phe
CCCG. After three rounds of
the selection, we obtained novel frameshift suppres-
sortRNAswhichhadhighdecodingactivityandgood
orthogonality against endogenous aminoacyl-tRNA
synthetases. These results demonstrate that the
in vitro selection system developed here is useful to
obtain highly active tRNAs for the incorporation of
non-natural amino acid from a tRNA library.
INTRODUCTION
Position-speciﬁc incorporation of non-natural amino acids
into proteins in a cell-free translation system is a powerful
technique for structural and functional analyses of proteins
and for design and synthesis of engineered proteins with
artiﬁcial functions (1–6). A majority of researchers has
been using an amber codon for assigning the positions of
non-natural amino acids. In this case, a UAG codon is decoded
by an amber suppressor tRNA that has been aminoacylated
with a non-natural amino acid. The amber suppression
method, however, has a disadvantage that the incorporation
of a non-natural amino acid must compete with a release factor
that binds to the amber codon and terminates the protein
synthesis. Alternatively, we have developed a four-base
codon strategy and successfully incorporated a wide variety
of non-natural amino acids into proteins (7–9). The four-base
decoding also must compete with a three-base decoding by
endogenous tRNAs. But the competition becomes in favor
by the use of four-base codons derived from rarely used
codons such as CGG and GGG. For efﬁcient incorpora-
tion of non-natural amino acids, it is also important to use
tRNAs that show high afﬁnity to a protein biosynthetic
machinery, especially to ribosome. There are several attempts
to ﬁnd efﬁcient tRNAs suitable for the amber suppres-
sion method from naturally occurring tRNAs (10,11).
The screening process is, however, time-consuming and
inefﬁcient, because each tRNA has to be synthesized,
aminoacylated and evaluated, separately. An improved
screening has been reported using in vivo selection of tRNAs,
selection of tRNAs, in which tRNAs recognized by any of
aminoacyl-tRNA synthetases are selected from randomly
mutated tRNA library (12,13). In their in vivo system,
however, tRNAs that are not recognized by aminoacyl-tRNA
synthetases cannot be selected. The selection of tRNA for
non-natural amino acid incorporation should be carried
out independently from the aminoacylation by any of
aminoacyl-tRNA synthetases.
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doi:10.1093/nar/gkl087Here, we propose a novel strategy to ﬁnd efﬁcient tRNAs
that are appropriate for in vitro four-base decoding to incorp-
orate non-natural amino acids. This strategy enables us to
select tRNAs that show high afﬁnity to translational machi-
nery from a tRNA library in a cell-free translation system. For
this strategy, a tRNA containing a puromycin moiety at
30-terminus was used. The puromycin–tRNA conjugate will
be fused to the C-terminus of an elongating peptide chain in a
ribosomal system. The efﬁciency of the fusion synthesis will
depend on relative population of tRNAs in the A site, that is
determined by the afﬁnity of each tRNA to the translational
machinery. As a consequence, tRNAs with high decoding
activity are selected by collecting the tRNA–peptide fusion.
In this study, we developed the selection system of tRNA
and then applied it to the selection of efﬁcient frameshift




Synthetic oligonucleotides were obtained from PROLIGO
JAPAN. 50-Phospho-deoxycytidyl-phospho-puromycin
(pdCp-puromycin) and a ﬂuorescently labeled primer
BFL-YF515 were from Japan Bio Services. QIAquick PCR
Puriﬁcation kit and MinElute PCR Puriﬁcation kit were pur-
chased from QIAGEN. KOD Dash DNA polymerase was from
TOYOBO. T7 RNA polymerase and Vent DNA polymerase
were from New England BioLabs. T4 RNA ligase, BcaBEST
RNA PCR kit ver1.1, GelStar Nucleic Acid Stain and ribo-
nuclease inhibitor were from TaKaRa BIO. Escherichia coli
S30 Extract System for Linear Templates and pGEM-T vector
were from Promega. Inorganic pyrophosphatase and
biotinamido-caproyl labeled BSA was from Sigma–Aldrich.
Dynabeads M-280 Streptavidin was from DYNAL. Pellet




Phe containing a CCCG anticodon and lacking a
30-terminal CA dinucleotide was prepared as described previ-
ously (8). The PCR mixture contained 0.1 nmol of an M13
Forward primer (CAACATTTTGCTGCCGGTCA), 0.1 nmol
of a 30-CA primer (GTGCGAATTCTGTGGATCGA), 0.1 mg
of a plasmid encoding a yeast tRNA
Phe gene under the
control of the T7 promoter in pUC18 (8), 0.2 mM dNTPs,
2 U of Vent DNA polymerase in 100 ml of Vent buffer. After
the PCR, the product was isolated by QIAquick PCR Puriﬁ-
cation kit. The PCR product was then supplied to a run-off
transcription reaction containing 40 mM Tris–HCl (pH 8.0),
20 mM MgCl2, 5 mM DTT, 4 mM NTP, 20 mM GMP, 2 mM
spermidine, 10 mg/ml BSA, 40 U of ribonuclease inhibitor,
1 U of inorganic pyrophosphatase, 400 U of T7 RNA poly-
merase and 10 mg of template DNA in 100 ml. After incubation
at37 Cfor18 h,the productwas puriﬁed ona DEAE-cellulose
column.
Construction of tRNA(-CA) library
A template DNA for the transcription of a tRNA library, in
which the 32nd, 33rd, 37th and 38th positions of the anticodon
loop were randomly mutated, was prepared using a primer
extension reaction and PCR. A tRNA-50 primer ATACGACT-
CACTATAGCGGATTTAGCTCAGTTGGG AGAGCGCC-
AGA containing a T7 promoter sequence, and a tRNA-AC
primer GACCTCCAGANNCGGGNNTCTGGCGCTC con-
taining a randomized anticodon loop sequence (NNCCCGNN,
in which N indicates 1 of 4 nt) were added to a primer
extension reaction containing KOD Dash buffer, 0.2 mM
dNTP, 50 pmol tRNA-50 primer, 50 pmol tRNA-AC primer,
1.25 U of KOD Dash DNA polymerase in a 50 ml reaction.
Using the resulting reaction mixture (1 ml) as a template, PCR
was carried out with a T7 promoter primer CTAATACGACT-
CACTATAG and a tRNA-30 primer GTGCGAATTCTGTG-
GATCGAACACAGGACCTCCAGA in 50 ml. The PCR
product was puriﬁed with MinElute PCR Puriﬁcation kit
and then subjected to a transcription reaction using T7
RNA polymerase as described above.
Preparation of puromycin–tRNA
Puromycin–tRNA was prepared by ligating pdCp-puromycin
to the tRNA(-CA) with T4 RNA ligase. The ligation reaction
mixture contained 55 mM HEPES-Na (pH 7.5), 10% DMSO
(v/v), 1 mM ATP, 15 mM MgCl2, 3.3 mM DTT, 20 mg/ml
BSA,0.5 nmol of tRNA(-CA), 1nmol of pdCp-puromycin and
30 U of T4 RNA ligase. After incubation at 4 C for 6 h, the
reaction mixture was extracted once with phenol/chloroform
and once with chloroform, precipitated with ethanol, and then
resolved in 10 ml of water. The ligation reaction was conﬁrmed
by 12% PAGE with 8 M urea, and the yield was estimated to
be 80%.
Preparation of a streptavidin mRNA containing CGGG
at C-terminus
A linker and CGGG sequence shown in Figure 2A was added
by PCR to a streptavidin gene that had been constructed (8).
The coding region of the resulting gene was ampliﬁed by PCR
using T7 promoter and T7 terminator primers, and then tran-
scribed to mRNA with T7 RNA polymerase as described
previously (8).
Expression of streptavidin–tRNA fusion in a cell-free
translation system
The expression of the streptavidin–tRNA fusion was
performed by the addition of the puromycin–tRNA and
the mRNA into an E.coli cell-free translation system. The
translation reaction mixture contained 55 mM HEPES–KOH
(pH 7.5), 210 mM potassium glutamate, 6.9 mM ammonium
acetate, 1.7 mM DTT, 1.2 mM ATP, 0.28 mM GTP,
26 mM phosphoenolpyruvate, 1 mM spermidine, 1.9%
poly(ethylene glycol)-8000, folinic acid at 35 mg/mL,
12 mM magnesium acetate, 0.1 mM each amino acids,
8 mg of mRNA, 100 pmol of puromycin–tRNA, and 2 ml
of E.coli S30 extract in 10 ml. The reaction mixture was
incubated at 37 C for 20 min, and then 4 ml of 0.5 M
EDTA was added to dissociate the streptavidin–tRNA fusion
from ribosome complex.
Collection of the streptavidin–tRNA fusion
The streptavidin–tRNA fusion was collected with biotin-
coated magnetic beads as follows. Biotinamido-caproyl
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Streptavidin, and gently shaken at room temperature for 20
min. The beads were washed three times with 200 mlo fT B S
(20 mM Tris–HCl, pH 7.5 and 150 mM NaCl) to remove
unbound biotinamido-caproyl BSA. The EDTA-treated trans-
lation mixture (14 ml) was added to the beads, and gently
shaken at room temperature for 20 min. The beads were sub-
sequently washed once with 200 ml of TBS, twice with 8 M
urea, once with 5 M NaCl, twice with TBST (TBS + 0.1%
Tween20), and ﬁnally once with TBS. The streptavidin–tRNA
fusion bound onto the magnetic beads was eluted in 50 mlo f
TESUB (10 mM Tris–HCl, pH 7.5, 1 mM EDTA, 1% SDS,
7 M urea and 8 mM biotin) by heating at 95 C for 10 min. The
collected streptavidin–tRNA fusion was ethanol-precipitated
with Pellet Paint NF Co-precipitant, and the pellet was
resuspended in 6 ml of water and subjected to reverse
transcription.
Reverse transcription and real-time quantitative PCR
Reverse transcription and real-time quantitative PCR were
performed using BcaBEST RNA PCR kit ver1.1. The reaction
mixture (20 ml) contained Bca ﬁrst buffer, 0.5 mM dNTPs,
22 U of BcaBEST polymerase, 0.5 mM YF315 primer GTGC-
GAATTCTGTGG complementary to the 30 region of the
tRNA and 2.5 ml of the recovered streptavidin–tRNA fusion.
After incubation at 65 C for 30 min, 6 ml portion was applied
to real-time quantitative PCR (30 ml) containing Bca 2nd
buffer, 0.75 U of Bca-optimized Taq, 0.2 mM YF315 and
0.2 mM BFL-YF515 primer that is complementary to the 50
region of the tRNA and contains BODIPY FL through a
C nucleotide at its 50 end (BODIPY FL-CGCGGATTTAGC-
TCAG). The ﬂuorescence intensity was monitored using
SmartCycler System (Cepheid) with a pre-PCR heat step of
4 min at 94 C, followed by 50 cycles of 30 s at 94 C, 30 s at
48 C,30s at 72 C. The cycle number at a deﬁned ﬂuorescence
intensity was determined for each sample, and the amount of
the recovered tRNA was calculated using a calibration curve
prepared from a series of non-mutated tRNA(-CA) solutions.
The RT–PCR product was conﬁrmed by 10% PAGE with
GelStar staining.
Regenerative PCR
The RT–PCR products were puriﬁed on a 10% PAGE, and
then ampliﬁed by overlap-extension PCR to regenerate the
tRNA(-CA) gene. A 50 primer T7YF526 which contained a
T7 promoter sequence and a complementary sequence to 26 nt
of the 50 region of the tRNA (CTAATACGACTCACTAT-
AGCGGATTTAGCTCAGTTGGGAGAGCG), and a 30
primer YF331 complementary to 31 nt of the 30 region of
thetRNA(-CA)(GTGCGAATTCTGTGGATCGAACACAG-
GACCT) were used. The PCR product was puriﬁed with
MinElute PCR Puriﬁcation kit and used as a template for
the tRNA pool for the next round of selection.
Evaluation of selected tRNAs
The selected tRNA genes were identiﬁed by TA-cloning and
sequencing. To evaluate the activity of the selected tRNAs for
the incorporation of non-natural amino acid, each clone was
transcribed to tRNA(-CA), and then ligated with a pdCpA
aminoacylated with a ﬂuorescently labeled amino acid,
BODIPY FL p-aminophenylalanine (14). The resulting
BODIPY FL p-aminophenylalanine-tRNA was added to the
E.coli cell-free translation system together with a streptavidin
mRNA containing a CGGG four-base codon at the Tyr83
position. The expression of the streptavidin containing
BODIPY FL p-aminophenylalanine was conﬁrmed by 15%
SDS–PAGE. The ﬂuorescence image was measured by a
ﬂuorescence image analyzer (FMBIO III; Hitachi software
engineering), and the band intensity of the ﬂuorescent strep-
tavidin was quantiﬁed. Using the SDS–PAGE gel, western
blotting was carried out using anti-T7 tag antibody.
To test the aminoacylation of the selected tRNAs by
endogenous aminoacyl-tRNA synthetases, each tRNA(-CA)
was ligated with non-aminoacylated pdCpA and then added
to the cell-free translation system together with the strepta-
vidin mRNA containing CGGG codon at the Tyr83 position.
The translation product was analyzed by western blotting
using anti-T7 tag antibody, and the relative yield of the full-
length streptavidin was quantiﬁed by comparing the band
intensity with those of serial dilutions of the wild-type
streptavidin.
RESULTS AND DISCUSSION
Strategy of in vitro selection of tRNA
In order to take up tRNAs that show high afﬁnity to trans-
lational machinery from a tRNA library, it is necessary to
collect tRNAs that are successfully incorporated into ribo-
some. For this purpose, we designed puromycin–tRNA that
contained a puromycin moiety in place of a 30-terminal
aminoacyl-adenosine unit (Figure 1A). The puromycin–tRNA
with a CCCG anticodon is expected to bind to ribosomal A
site, when a CGGG four-base codon comes to the A site. In the
present case, a streptavidin mRNA containing a four-base
codon CGGG at the 30-terminus of streptavidin gene was
added to a cell-free translation system. When the CGGG is
decoded by the puromycin–tRNACCCG, a peptide bond will be
formed between the amino group of the puromycin moiety and
the carboxyl group of the C-terminus of streptavidin. The
resulting streptavidin–puromycin–tRNA may be translocated
to the P-site. In this case, the next aminoacyl-tRNA binds
to the vacant ribosomal A site, but can not react with the
streptavidin–puromycin–tRNA because the corresponding
carbonyl group of the growing streptavidin is linked to the
tRNACCCG through an amide bond instead of an ester bond.
Consequently, a covalently-linked streptavidin–tRNA fusion
will remain seated in the ribosome–mRNA complex. This
complex can be dissociated by the addition of EDTA, and
the covalently-linked streptavidin–tRNA fusion will be
released from the complex. The streptavidin–tRNA fusion
can be collected by biotin-immobilized materials, like biotin-
coated magnetic beads. Although an enzymatically amino-
acylated tRNA containing 30-amino-30-deoxyadenosine at its
30-terminus had been utilized for ribosome display (15), we
independently designed the puromycin–tRNA conjugate and
utilized it for in vitro selection of tRNA.
Using the puromycin–tRNA conjugate and streptavidin
gene, selection of tRNAs is performed according to a scheme
Nucleic Acids Research, 2006, Vol. 34, No. 5 1655Figure 1. (A) Schematic illustration of the formation of streptavidin–tRNA fusion using puromycin–tRNA, which contains a puromycin moiety in the place of
30 terminalaminoacyl-adenosineanda four-baseanticodon CCCG.Thepuromycin–tRNA bindsto ribosomalAsiteand acceptsa streptavidinpolypeptidechainas
an analog of aminoacyl-tRNA in response to a four-base CGGG codon at 30 terminus of streptavidin mRNA in a cell-free translation. The resulting streptavidin–
puromycin–tRNA may be translocated to the P-site. In this case, the next aminoacyl-tRNA binds to the vacant ribosomal A site, but can not accept the polypeptide
chain because of the amide bond of puromycin–tRNA. The resulting streptavidin–tRNA fusion is released from the ribosome complex by the addition of EDTA.
(B)SchematicillustrationoftheinvitroselectionsystemoftRNAs.Step1,aDNApoolencodingtRNAscontainingafour-baseanticodonCCCGistranscribedbyT7
RNA polymerase to tRNA(-CA) pool. Step 2, the tRNA(-CA) pool is ligated with pdCp-Puromycin by T4 RNA ligase to generate puromycin–tRNA. Step 3, a
streptavidinmRNAcontainingafour-baseCGGGcodonatC-terminusistranslatedinanE.colicell-freetranslationsysteminthepresenceofthepuromycin–tRNA.
Puromycin–tRNAs that successfully decode the CGGG codon form ribosome–mRNA–streptavidin–tRNA complex. Step 4, the streptavidin–tRNA fusion is
dissociated from the complex by the addition of EDTA. Step 5, the streptavidin–tRNA fusion is recovered with biotin-coated magnetic beads. Step 6, the
streptavidin–tRNA fusion is dissociated from the beads, and then the tRNA moiety is subjected to RT–PCR. Step 7, the tRNA genes are regenerated by
overlap-extension PCR with a T7 promoter primer, which are used as template DNAs in the next round of selection.
1656 Nucleic Acids Research, 2006, Vol. 34, No. 5of Figure 1B. First, a DNA pool encoding T7 promoter and
tRNAs containing a four-base anticodon CCCG is designed
andconstructed. The DNA poolisthen transcribedby T7RNA
polymerase to give a pool of tRNAs lacking 30-terminal dinu-
cleotide. ThetRNA(-CA) poolis then ligatedwith50-phospho-
deoxycytidyl-phospho-puromycin (pdCp-puromycin) by T4
RNA ligase to obtain a puromycin–tRNA conjugate pool.
The puromycin–tRNA conjugates are added to a cell-free
translation system together with a streptavidin mRNA
containing a four-base CGGG codon at the C-terminus. The
puromycin–tRNA conjugates that were successfully incorpo-
rated into the ribosome form streptavidin–tRNA fusions in
a ribosome complex. The streptavidin–tRNA fusions are
dissociated from the complex by the addition of EDTA,
and recovered with biotin-coated magnetic beads. A pool of
the recovered streptavidin–tRNA fusion is subjected to
RT–PCR. After overlap-extension PCR to regenerate a
DNA pool encoding tRNAs under the control of the T7
promoter, a pool of tRNAs is prepared and applied to the
next round of selection. Multiple cycles of selection will
enrich the tRNAs that show high decoding activity in the
translation system.
Formation of streptavidin–tRNA fusion
Formation of the fusion of tRNACCCG and streptavidin was
ﬁrst examined. A modiﬁed streptavidin gene containing ﬁve
CGGG codons (CGGGTC CGGGCA CGGGTG CGGGCT
CGGGTC)atthedownstreamendofstreptavidingenethrough
a linker sequencewas designed andconstructed (Figure2A).If
the ﬁrst CGGG was decoded as a CGG three-base codon to
arginine, then the second CGGG four-base appears. If the
second CGGG was also decoded as a three-base codon,
then the third appear, and so on. So, the repeated CGGG
codons will markedly enhance the efﬁciency of the four-base
decoding by the puromycin–tRNACCCG and decoding of any
of the ﬁve CGGG codons by the puromycin–tRNACCCG will
give the streptavidin–tRNA fusion. On the other hand, if all of
the ﬁve CGGG codons are translated by endogenous arginyl-
tRNACCG, free streptavidin that does not contain the
puromycin–tRNA conjugate will be produced by a UAA
stop codon at the 30 end. The linker peptide sequence Gly-
GlySerGlyGlySer will serve to help tetramerization of strepta-
vidin.TheDNA encoding the streptavidin–5·CGGG genewas
prepared by overlap-extension PCR, and the corresponding
Figure 2. Formation of streptavidin–tRNA fusion and recovery of the corresponding tRNA gene using yeast tRNAPhe
CCCG.( A) An mRNA sequence used for the
formation of streptavidin–tRNA fusion. The streptavidin gene contains T7 tag at N-terminus for the detection by western blot analysis, and five CGGG codons at
C-terminusthroughalinkersequenceconsistedofGlyGlySerGlyGlySersequence.(B)Westernblotanalysisoftheformationofstreptavidin–tRNAfusionbyadding
the streptavidin mRNA to a cell-free translation system in the absence of the puromycin–tRNA, in the presence of the puromycin–tRNA, and in the presence of the
puromycin-tRNA and after treatment with RNaseA. (C) The amount of tRNA recovered with biotin-coated magnetic beads as streptavidin–tRNA fusion was
determinedbyquantitativePCRanalysis.ThetRNAswererecoveredfromthecell-freetranslationproductsobtainedinthepresenceofmRNAwithoutCGGGcodon,
and with five CGGG codons at C-terminus. (D) PAGE analysis of the RT–PCR product of the recovered tRNAs obtained in the presence of mRNA without CGGG
codon, and with five CGGG codons at C-terminus. The RT–PCR product of the yeast tRNAPhe
CCCG(-CA) was applied as a positive control.
Nucleic Acids Research, 2006, Vol. 34, No. 5 1657mRNA was synthesized by T7 RNA polymerase as previously
described. Puromycin–tRNA conjugate was prepared by a
chemical aminoacylation method (16) using pdCp-puromycin
and a synthetic yeast tRNA
Phe lacking 30 CA dinucleotide and
containing a CCCG four-base anticodon.
The puromycin–yeast tRNA
Phe
CCCG conjugate and the mRNA
were added to an E.coli cell-free translation system. The trans-
lation product was analyzed by western blot using an anti-T7
tag monoclonal antibody to detect T7-tagged translation prod-
ucts. As shown in Figure 2B, in the presence of the
puromycin–tRNA conjugate, a band was observed around
43 kDa corresponding to the expected molecular weight of
the streptavidin–tRNA fusion. On the other hand, in the
absence of the puromycin–tRNA, only free streptavidin was
observed around 20 kDa. When the translation product
obtained in the presence of the puromycin–tRNA was treated
with RNaseA, the band around 43 kDa disappeared. These
results suggest that the covalently-linked tRNA–streptavidin
fusion is successfully obtained as the 43 kDa band. When a
streptavidin mRNA containingone CGGG sequence was used,
only a weak band was observed around 43 kDa, indicating the
effectiveness of the ﬁve CGGG sequences.
Recovery of yeast tRNA
Phe
CCCG and quantitative RT–PCR
Next, selective recovery of the streptavidin–yeast
tRNAPhe
CCCGfusion by biotin-coated magnetic beads was
investigated. To the cell-free translation mixture, EDTA
was added to release the covalently-linked streptavidin–tRNA
fusion from ribosome–mRNA complex. The streptavidin–
tRNA fusion was collected by biotin-coated magnetic
beads, and was used as a template of RT–PCR. Reverse
transcription was performed at 65 C using a thermostable
RT. Under this condition, tRNA molecules could be unfolded
to facilitate the reverse transcription.
The quantitative PCR was then performed according to a
method reported by Kurata et al. (17), in which a primer
containing BODIPY FL and cytosine at 50 end was used.
When the BODIPY FL-labeled primer becomes double-
stranded by PCR ampliﬁcation, the ﬂuorescence of BODIPY
FL will be quenched by a guanine unit on the opposite strand.
The PCR process was followed by the decrease of the ﬂuo-
rescence of BODIPY FL. The cycle number at which the
ﬂuorescenceintensityreached adeﬁned value wasdetermined,
and the initial amount of tRNA was calculated from the cycle
number using a calibration curve prepared from a series of
tRNA(-CA) solutions. As shown in Figure 2C, 2.6 · 10
11
molecules of tRNA were found to be recovered from the
puromycin–tRNA conjugate after in vitro translation in the
presence of streptavidin mRNA containing ﬁve CGGG
sequences. The RT–PCR product was analyzed on 10%
PAGE, and a band of 76 bp corresponding to the tRNA
gene was observed (Figure 2D). The recovered tRNA genes
were then cloned, and 20 clones were randomly picked up and
sequenced. All of the 20 clones were identical to the yeast
tRNAPhe
CCCG. On the other hand, after the in vitro translation in
the presence of mRNA that did not contain the CGGG
sequence, only 2.0 · 10
9 molecules of tRNA were recovered.
The very small amount of tRNA may be resulted from a
non-speciﬁc adsorption of the puromycin–tRNA conjugates
to the magnetic beads. These results demonstrate that the
puromycin–tRNACCCG fused to streptavidin is recovered by
the biotin-coated magnetic beads, and that the tRNA can be
successfully reverse-transcribed despite of a large streptavidin
moiety that is fused. In addition, the result supports that the
puromycin–tRNACCCG conjugate is incorporated into ribo-
some in response to the four-base codon CGGG, and that
the unreacted puromycin–tRNACCCG conjugate can be
removed from the beads by washing.
The amount of the recovered tRNA (2.6 · 10
11 molecules)
corresponds to 0.4% of the added puromycin–tRNA (6.0 ·
10
13 molecules). Because of the limited amount of mRNA
and ribosome in the cell-free translation system, and
limited productivity of the cell-free system, not all of the
puromycin–tRNA initially added will form the
streptavidin–tRNA fusion. The recovery rate (0.4%) is thought
to be sufﬁcient for the effective selection.
Selection of tRNAs from a tRNA library with randomly
mutated anticodon loops
The in vitro selection system for tRNAs was then utilized to
obtain tRNAs that are effective for the four-base decoding
from a tRNA library with randomly mutated anticodon
loops. In this work, random mutations were carried out at
the 32nd, 33rd, 37th and 38th positions in the anticodon
loop of yeast tRNAPhe
CCCG(Figure 3A). Because one additional
nucleotide unit has been inserted to the anticodon loop of the
tRNACCCG, optimization of the anticodon loop will be essen-
tial for ﬁnding efﬁcient tRNAs. A pool of template DNA was
synthesized by PCR with three synthetic oligonucleotides
including the random mutations. The sequence analysis of
20 tRNA clones from the non-selected pool indicates the
32nd, 33rd, 37th and 38th positions are randomly mutated.
Then a pool of puromycin–tRNACCCG conjugates was pre-
pared and added to the cell-free translation system together
with the streptavidin mRNA containing ﬁve CGGG codons at
the C-terminus. Puromycin–tRNA conjugates that show high
afﬁnity to the translational machinery were expected to
form streptavidin–tRNA fusions preferentially. The
streptavidin–tRNA fusion was recovered with the biotin-
coated magnetic beads and subjected to quantitative
RT–PCR. The RT–PCR product was then used as a template
for the next round of selection.
The amount of recovered tRNA in each round of selection is
shown in Figure 3B. At the ﬁrst round, only a very small
amount of tRNA was recovered. The recovered tRNA, how-
ever, increased markedly and reached saturation level after the
second round. Western blot analysis of the cell-free translation
product also indicated that the streptavidin–tRNA fusion was
successfully obtained afterthe secondand third round of selec-
tion, whereas only very small amount of the fusion was
obtainedafter theﬁrstround(Figure3C).These resultssuggest
that the tRNAs with high decoding activity are accumulated
rapidly from the randomized pool.
ThetRNA genesrecoveredafter thethirdroundwere cloned
and sequenced. Of 43 clones picked up, 8 CU-CCCG-AA,
5 CU-CCCG-AU, 4 CA-CCCG-AA, 3 UC-CCCG-AC,
2 UU-CCCG-AC and AU-CCCG-AC, and 19 single clones
were found (Table 1). The anticodon loop sequence CU-AA
and UU-AC are naturally occurring in E.coli tRNAs (E.coli
tRNA
Ala1B has a UU-UGC-AC anticodon loop), but others are
1658 Nucleic Acids Research, 2006, Vol. 34, No. 5not. The result indicates that the selection system gives tRNAs
of non-natural sequences which differ from natural ones, and
some of them may have high decoding activity in the cell-free
translation system.
Activity of the selected tRNAs for the translation of a
CGGG four-base codon to a non-natural amino acid
Activity of the above six clones for the incorporation of non-
natural amino acid was evaluated by using a ﬂuorescently
labeled non-natural amino acid, BODIPY FL p-aminophenyl-
alanine. This non-natural amino acid has been found to be
incorporated into proteins in moderate efﬁciency, and allows
us to quantify the decoding activity of tRNAs. The six tRNA
genes were transcribed to tRNA(-CA)s, and latters were
chemically aminoacylated with BODIPY
FL-aminophenylalanine. The aminoacyl-tRNAs were added
to the E.coli cell-free translation system together with a strep-
tavidin mRNA containing a CGGG codon at the Tyr83 posi-
tion. The translation product was subjected to SDS–PAGE and
analyzed on a ﬂuorescence image analyzer and by western
blotting. As shown in Figure 4A, the full-length streptavidin
was observed both in a ﬂuorescence image of the SDS–PAGE
and in a western blotting for all clones. On the other hand,
tRNAs with CC-CCCG-CC, GG-CCCG-GG, UU-CCCG-UU
anticodonloopsequences, which were notobtainedinthe third
round of selection, gave no ﬂuorescent band, supporting the
speciﬁcity of the selection system. The band intensities of the
ﬂuorescence image were quantiﬁed, and shown in Figure 4B.
These results indicate that all of the selected tRNAs are active
for non-natural amino acid incorporation. Particularly the
tRNAs with CU-CCCG-AA and CU-CCCG-AU anticodon
loops show very high activity. The activity of the tRNAs
with CU-CCCG-AU sequence is comparable to that of the
original yeast tRNA
Phe with CU-CCCG-AA sequence. The
result demonstrates that the present in vitro selection system
for tRNA is working effectively to obtain novel tRNA
sequences that are appropriate for decoding CGGG four-base
codon and for incorporating a non-natural amino acid. Further
random mutagenesis at various regions of the tRNA will
enhance the possibility of increasing the decoding activity
of the tRNA.
Orthogonalityoftheselected tRNAsagainstendogenous
aminoacyl-tRNA synthetases in an E.coli system
Transfer RNAs for the incorporation of non-natural amino
acids should not be recognized by any endogenous
aminoacyl-tRNA synthetases in a cell-free translation system,
otherwise its aminoacylation with any naturally occurring
amino acid will result in the incorporation of the natural
Figure 3. Selection of tRNA from a random pool library of yeast tRNA
Phe
containing NN-CCCG-NN in anticodon loop. (A) Structure of tRNA(-CA), in
whichNindicatesA,G,CorU.(B)TheamountofrecoveredtRNAdetermined
byquantitativePCRineachroundofselection.(C)Westernblotanalysisofthe
streptavidin–tRNA fusion obtained in the each round of selection.
Table 1. The sequences of anticodon loop of the selected tRNAs








Nucleic Acids Research, 2006, Vol. 34, No. 5 1659one. To test the aminoacylation of the selected tRNAs by
endogenous aminoacyl-tRNA synthetases, translation was
performed in the presence of non-aminoacylated tRNAs.
The latters were prepared by ligation with non-aminoacylated
pdCpA by T4 RNA ligase, and added to the cell-free trans-
lation system together with the mRNA containing a CGGG
four-base codon at the Tyr83 position. The translation prod-
ucts were analyzed by western blotting and the yield of the
full-length product was quantiﬁed by densitometric analysis.
Theresults(Figure5)showedthe selected tRNAsgave smaller
amount of the full-length product than the original tRNA with
CU-CCCG-AA anticodon loop. This result suggests that the
selected ﬁve types of tRNAs have better orthogonality against
endogenous E.coli aminoacyl-tRNA synthetases than the
original yeast tRNAPhe
CCCGthat is slightly aminoacylated by




amino acid into Tyr83 position of streptavidin by using the selected and unselected tRNAs. (B) Relative fluorescence intensity of the band of streptavidin. The data
were represented as mean ± SD of six assays.
1660 Nucleic Acids Research, 2006, Vol. 34, No. 5high decoding activity of the tRNA with CU-CCCG-AU
anticodon loop makes it more suitable for incorporation of
non-natural amino acids in response to a CGGG four-base
codon than the original yeast tRNA
Phe.
CONCLUSION
We developed a novel selection system for tRNAs that are
efﬁcient in incorporatingnon-natural aminoacidsinto proteins
through four-base decoding. We demonstrated that the genes
of tRNAs that facilitate the incorporation of non-natural amino
acids in a cell-free translation system were speciﬁcally recov-
ered from a library of puromycin–tRNA conjugates. Several
novel tRNAs with different sequences in the anticodon loop
obtained by selecting from a tRNA library with a randomly
mutated anticodon loop. Particularly, the tRNA with
CU-CCCG-AU sequence showed high efﬁciency of non-
natural amino acid incorporation and strict orthogonality
against any endogenous aminoacyl-tRNA synthetases.
The most important advantage of the in vitro selection
strategy is that desired clones could be selected from a very
large library. In this system, it is possible to input 6.0 · 10
13
molecules of tRNAs with randomized sequences into a 10 ml
of the cell-free translation reaction. Novel tRNAs that are
superior to yeast tRNAPhe
CCCGin the orthogonality and the
activity for the incorporation of non-natural amino acids
may be selected from a much larger library. We selected
here frameshift suppressor tRNAs decoding a four-base
codon CGGG in an E.coli cell-free translation system.
However, this selection system will be applicable to other
tRNAs such as nonsense suppressor tRNAs and conventional
triplet tRNAs in other cell-free translation systems such as
rabbit reticulocyte and wheat germ systems.
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